Nonmelanoma Skin Cancer
News
FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
From the Journals
Age, smoking among leading cancer risk factors for SLE patients
While older age was a risk factor for both breast and nonmelanoma skin cancers, use of antimalarial drugs lowered the risk of both.
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
Original Research
Scalp Wound Closures in Mohs Micrographic Surgery: A Survey of Staples vs Sutures
Limited data exist comparing staples and sutures for closing scalp wounds during Mohs micrographic surgery. The authors surveyed practicing Mohs...
Commentary
Risk Factors and Management of Skin Cancer Among Active-Duty Servicemembers and Veterans
Active-duty servicemembers of the US Military experience unique exposures that should be taken into consideration when determining their risk for...
Case Letter
Mycosis Fungoides Manifesting as a Morbilliform Eruption Mimicking a Viral Exanthem
Mycosis fungoides classically occurs in patch, plaque, and tumor stages, with lesions preferentially occurring on regions of the body spared from...
Case Reports
Anti–PD1 Immune Checkpoint Inhibitor–Induced Bullous Pemphigoid in Metastatic Melanoma and Non–Small Cell Lung Cancer
Anti–programmed cell death 1 targeted therapies improve survival in solid and hematologic malignancies but are associated with autoimmune side...
Original Research
Topical Clobetasol Propionate Treatment and Cutaneous Adverse Effects in Patients With Early-Stage Mycosis Fungoides: An Observational Study
In this observational study, we aimed to evaluate the risk for skin adverse events of clobetasol propionate cream 0.05% in patients with early-...
Conference Coverage
MCC response varies based on immunosuppression type, especially CLL
News from the FDA/CDC
FDA approves pomalidomide for Kaposi sarcoma
From the Journals
Neoadjuvant nivolumab ‘promising’ in Merkel cell carcinoma
“To our knowledge, this is the first study to examine neoadjuvant anti-PD-1 therapy in MCC,” said lead author Suzanne Topalian, MD.